MCY-27506-62850
4 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 018 / MA
- Registered
- 2022-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Dose 1 — Moderna
-
2021-04-06
Dose 2 — Moderna
-
2021-12-09
Dose 3 — Pfizer-BioNTech
-
2022-11-15
Dose 4 — Other-UnknownCo-administered: Flu
-
2022-12-24
Registered in v-safe
-
2022-12-24
Survey response — day 35, dose 4MedDRA: Nasal congestion, Sneezing — Feeling: FairFree text: Nasal congestion, sneezingMedDRA releases: 2024-11 · check-in free text available
- 2022-12-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Moderna | No |
| 2 | 2021-04-06 | Moderna | No |
| 3 | 2021-12-09 | Pfizer-BioNTech | No |
| 4 | 2022-11-15 | Other-Unknown | Flu |
Free text
Release 12 — day 35, dose 4
Symptoms: Nasal congestion, sneezing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release